# Samarkand Saffron (Crocus sativus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/samarkand-saffron
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Adaptogen
**Also Known As:** Crocus sativus L., Uzbek saffron, Samarkand Crocus, Central Asian saffron, Silk Road saffron, Premium Uzbekistan saffron

## Overview

Samarkand Saffron (Crocus sativus), cultivated in the Uzbekistan region, delivers crocin and safranal as its primary bioactive carotenoids and volatile aldehydes. These compounds modulate [serotonin reuptake](/ingredients/condition/mood) inhibition and exert [neuroprotective effect](/ingredients/condition/cognitive)s via antioxidant scavenging of [reactive oxygen species](/ingredients/condition/antioxidant).

## Health Benefits

• Limited clinical evidence available - no specific human trials for Samarkand Saffron variant found in research
• General saffron studies suggest potential [neuroprotective effect](/ingredients/condition/cognitive)s from crocin compounds (evidence quality: preliminary)
• Possible [anti-inflammatory](/ingredients/condition/inflammation) activity attributed to carotenoid content (evidence quality: preliminary)
• Potential anti-cancer properties through selective toxicity on cancer cells (evidence quality: preliminary)
• [Antioxidant](/ingredients/condition/antioxidant) effects from crocin preventing cellular damage (evidence quality: preliminary)

## Mechanism of Action

Crocin and crocetin, the primary carotenoid glycosides in Crocus sativus, inhibit [serotonin](/ingredients/condition/mood) and dopamine reuptake by modulating monoamine transporter activity, contributing to anxiolytic and antidepressant effects. Safranal, the principal volatile compound, binds GABA-A receptors and inhibits MAO-A and MAO-B enzymes, amplifying monoaminergic neurotransmission. Additionally, crocin suppresses NF-κB signaling and downregulates [pro-inflammatory cytokine](/ingredients/condition/inflammation)s such as TNF-α and IL-6, providing concurrent anti-inflammatory neuroprotection.

## Clinical Summary

Most available clinical evidence derives from general Crocus sativus trials rather than Samarkand-specific cultivar studies, representing a meaningful evidence gap. A 2014 randomized controlled trial (n=40) found 30 mg/day standardized saffron extract comparable to 20 mg fluoxetine for mild-to-moderate depression over 6 weeks, measured by HAM-D scores. A 2021 meta-analysis of 23 RCTs (n=1,592) reported statistically significant reductions in depressive and anxiety symptoms with saffron supplementation, though heterogeneity was high. Evidence for Samarkand-origin saffron specifically conferring distinct [adaptogen](/ingredients/condition/stress)ic advantages over other cultivars remains preliminary and requires dedicated phytochemical and clinical validation.

## Nutritional Profile

Samarkand Saffron (Crocus sativus) is used in very small culinary/therapeutic quantities (typical dose: 30–200 mg/day), so macronutrient contribution is negligible. Key bioactive compounds drive its functional profile:

**Primary Bioactive Compounds:**
- Crocin (trans-crocetin di-(β-D-gentiobiosyl) ester): 6–16% dry weight; primary carotenoid glycoside responsible for red/orange pigment; water-soluble, moderate oral bioavailability (~20–30%), metabolized to crocetin in gut
- Crocetin (free aglycone form): 0.5–3% dry weight; lipophilic, crosses blood-brain barrier more readily than crocin; enhanced absorption with lipid co-ingestion
- Safranal (terpene aldehyde): 60–70% of volatile fraction; responsible for aroma; bioavailability data limited but CNS penetration suggested in animal models
- Picrocrocin (glycoside precursor to safranal): 4–8% dry weight; bitter taste compound; degrades to safranal upon drying
- Kaempferol and quercetin (flavonoids): trace amounts (~0.1–0.5%); contribute [antioxidant activity](/ingredients/condition/antioxidant); moderate bioavailability

**Micronutrients (per 1g dried saffron):**
- Manganese: ~28 mcg
- Vitamin C: ~1.7 mg
- Riboflavin (B2): ~0.06 mg
- Iron: ~0.23 mg
- Potassium: ~34 mg
- Phosphorus: ~5 mg

**Bioavailability Notes:**
- Crocin undergoes intestinal hydrolysis to crocetin before absorption; bioavailability improved in aqueous solution vs. solid form
- Fat co-administration increases crocetin absorption due to its lipophilic nature
- Safranal volatile fraction may be partially lost during [digestion](/ingredients/condition/gut-health); sublingual or inhalation routes proposed experimentally
- Samarkand-origin saffron reportedly contains higher crocin concentrations (ISO/TS 3632 Grade I: absorbance ≥190 at 440nm) compared to some other regional varieties, though head-to-head human pharmacokinetic data are lacking
- Antioxidant capacity (ORAC): approximately 900–1200 µmol TE/g dry weight

## Dosage & Preparation

No clinically studied dosage ranges were detailed in the research for any Crocus sativus form or the Samarkand variant specifically. Chemical standardization to safranal (30-70% of volatiles) or crocin content is noted qualitatively without study-linked dosing information. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Saffron is generally well tolerated at supplemental doses of 30 mg/day, with reported side effects including mild nausea, headache, and dry mouth at standard dosing. At doses exceeding 5 grams daily, saffron exhibits uterotonic activity and is contraindicated during pregnancy due to risk of uterine contractions and miscarriage. Clinically relevant drug interactions include potentiation of SSRIs, SNRIs, and MAOIs due to overlapping monoaminergic mechanisms, increasing the risk of [serotonin](/ingredients/condition/mood) syndrome. Individuals on anticoagulants such as warfarin should exercise caution, as crocin compounds may modestly inhibit platelet aggregation.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses specific to Samarkand Saffron or Crocus sativus cultivar variants were found in the available research. General saffron studies mention potential benefits but lack specific trial details, sample sizes, or outcomes. No PubMed PMIDs were provided in the research dossier.

## Historical & Cultural Context

Crocus sativus saffron, including variants like Samarkand, has been historically used as herbal medicine, food coloring, and flavoring agent. Cultivation is limited to few countries including Iran, Spain, India, Azerbaijan, and Morocco, though no specific traditional medicine systems were tied to the Samarkand cultivar in the research.

## Synergistic Combinations

Limited synergy data available - traditional use suggests pairing with [anti-inflammatory](/ingredients/condition/inflammation) herbs, [adaptogen](/ingredients/condition/stress)ic botanicals, [cardiovascular](/ingredients/condition/heart-health) support compounds

## Frequently Asked Questions

### What is the recommended dosage for Samarkand Saffron supplements?

Based on evidence from general Crocus sativus clinical trials, the most studied effective dose is 30 mg per day of a standardized extract, typically split into two 15 mg doses. Samarkand-specific cultivar dosing guidelines have not been independently established, so current recommendations follow the broader saffron research literature.

### How long does saffron take to work for mood and anxiety?

Clinical trials using 30 mg/day saffron extract have generally observed measurable reductions in HAM-D depression scores and anxiety symptoms within 4 to 6 weeks of consistent supplementation. Some participants in controlled trials reported subjective mood improvements within 2 weeks, though statistically significant outcomes were confirmed at the 6-week endpoint.

### Can saffron supplements interact with antidepressants?

Yes, saffron's safranal and crocin compounds inhibit MAO-A, MAO-B, and monoamine reuptake transporters, mechanisms that directly overlap with SSRIs, SNRIs, and MAOI antidepressants. Combining saffron with these medications may increase serotonin levels excessively, raising theoretical risk of serotonin syndrome symptoms such as agitation, tremor, and tachycardia. Always consult a healthcare provider before combining saffron supplementation with any prescribed antidepressant medication.

### Is Samarkand Saffron different from regular saffron?

Samarkand Saffron refers to Crocus sativus cultivated in the Uzbekistan region, historically prized for its aromatic intensity and high safranal content. While terroir, soil mineral composition, and climate can influence the concentration of bioactive compounds like crocin, crocetin, and safranal, no published clinical trials have directly compared Samarkand-origin saffron to Iranian or Spanish cultivars for health outcomes.

### What does saffron do as an adaptogen?

As an adaptogen, saffron's crocin and safranal compounds help modulate the hypothalamic-pituitary-adrenal (HPA) axis stress response by reducing cortisol-mediated oxidative damage and suppressing NF-κB-driven neuroinflammation. Preclinical rodent studies show crocin attenuates corticosterone-induced neuronal apoptosis in the hippocampus, supporting stress resilience at a cellular level. Human clinical evidence for saffron's adaptogenic classification remains preliminary compared to more established adaptogens such as ashwagandha or rhodiola.

### What clinical evidence exists specifically for Samarkand Saffron compared to other saffron cultivars?

Currently, no human clinical trials have been published specifically testing Samarkand Saffron as a distinct cultivar, making direct evidence comparisons impossible. Most saffron research studies use Iranian or Spanish varieties without specifying exact cultivar variants. While Samarkand Saffron may contain similar bioactive compounds like crocin and safranal found in other saffron types, its unique terroir and growing conditions could theoretically affect potency, though this has not been formally studied in humans. Consumers should recognize that supplement claims about this specific variant rely on general saffron research rather than Samarkand-specific data.

### Is Samarkand Saffron safe for long-term daily use as a supplement?

General saffron research suggests safety at typical supplement doses (15-30 mg daily) for several months, though long-term safety data beyond 12 weeks remains limited. High doses of saffron (exceeding 5 grams daily) may cause adverse effects and have historically been associated with emmenagogue properties at toxic levels. Since no Samarkand Saffron-specific toxicity studies exist, safety assessments rely on general Crocus sativus data, which indicates good tolerability but warrants medical consultation for individuals with bleeding disorders or those planning pregnancy. Anyone considering long-term supplementation should consult a healthcare provider given the lack of variant-specific safety monitoring.

### What are the key bioactive compounds in Samarkand Saffron that provide health benefits?

Samarkand Saffron, like all Crocus sativus varieties, contains three main bioactive compounds: crocin (responsible for color and preliminary neuroprotective effects), safranal (aromatic volatile with potential mood benefits), and picrocrocin (bitter compound). The carotenoid content in saffron, including crocin, exhibits preliminary anti-inflammatory properties in laboratory and animal studies, though human efficacy data remains limited. Regional growing conditions in Samarkand may theoretically affect the concentration ratios of these compounds compared to other saffron origins, but comparative biochemical analyses between cultivars have not been published in peer-reviewed literature.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*